Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Atara Biotherapeutics, Inc. (ATRA) vs Cognition Therapeutics, Inc. (CGTX)

Atara Biotherapeutics, Inc. and Cognition Therapeutics, Inc. are both Biotechnology companies. Atara Biotherapeutics, Inc. and Cognition Therapeutics, Inc. are of similar size ($90.7M and $85.7M). Cognition Therapeutics, Inc. has the higher net margin (0.00% vs −269.4%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, Atara Biotherapeutics, Inc. leads on 6 and Cognition Therapeutics, Inc. on 5.

Valuation

Metric ATRA CGTX Biotechnology median
P/E n/m n/m 7.88
P/S 21.38 n/m 11.47
P/B n/m 2.58 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 19.79 n/m 10.73
Earnings yield (13.39%) (18.09%) (28.84%)
Free cash flow yield (15.88%) (20.77%) (23.03%)

Profitability

Metric ATRA CGTX Biotechnology median
Gross margin 91.38% 0.00% 65.16%
Operating margin (229.67%) 0.00% 0.00%
Net margin (269.42%) 0.00% 0.00%
Free cash flow margin (353.49%) 0.00% 0.00%
Return on equity 46.33% (83.76%) (57.72%)
Return on assets (57.62%) (57.33%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ATRA CGTX Biotechnology median
Revenue growth (TTM) (96.72%) — 5.64%
EPS growth (last fiscal year) 122.52% 62.79% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ATRA CGTX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.98 7.03 4.73
Net debt to EBITDA (0.22) 0.78 0.96

Dividend

Metric ATRA CGTX Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric ATRA CGTX Biotechnology median
Market cap 85.72m 90.68m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack